265 related articles for article (PubMed ID: 35052376)
21. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
[TBL] [Abstract][Full Text] [Related]
22. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children.
Aaltio J; Hyttinen V; Kortelainen M; Frederix GWJ; Lönnqvist T; Suomalainen A; Isohanni P
Eur J Paediatr Neurol; 2022 Jan; 36():30-36. PubMed ID: 34852981
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
[TBL] [Abstract][Full Text] [Related]
24. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
[TBL] [Abstract][Full Text] [Related]
25. Dendritic Spine in Autism Genetics: Whole-Exome Sequencing Identifying De Novo Variant of
Xie Y; Wang H; Hu B; Zhang X; Liu A; Cai C; Li S; Chen C; Wang Z; Yin Z; Wang M
Children (Basel); 2022 Dec; 10(1):. PubMed ID: 36670631
[TBL] [Abstract][Full Text] [Related]
26. Clinical utility and cost-effectiveness analysis of chromosome testing concomitant with chromosomal microarray of patients with constitutional disorders in a U.S. academic medical center.
Su M; Page S; Haag M; Swisshelm K; Hennerich D; Graw S; LeRoux J; Brzeskiewicz P; Svihovec S; Bao L
J Genet Couns; 2022 Apr; 31(2):364-374. PubMed ID: 34397147
[TBL] [Abstract][Full Text] [Related]
27. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
[TBL] [Abstract][Full Text] [Related]
28. Autism Prevalence and Severity in Bedouin-Arab and Jewish Communities in Southern Israel.
Levaot Y; Meiri G; Dinstein I; Menashe I; Shoham-Vardi I
Community Ment Health J; 2019 Jan; 55(1):156-160. PubMed ID: 29388003
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic yield of chromosomal microarray and trio whole exome sequencing in cryptogenic cerebral palsy.
Yechieli M; Gulsuner S; Ben-Pazi H; Fattal A; Aran A; Kuzminsky A; Sagi L; Guttman D; Schneebaum Sender N; Gross-Tsur V; Klopstock T; Walsh T; Renbaum P; Zeligson S; Shemer Meiri L; Lev D; Shmueli D; Blumkin L; Lahad A; King MC; Levy EL; Segel R
J Med Genet; 2022 Aug; 59(8):759-767. PubMed ID: 34321325
[TBL] [Abstract][Full Text] [Related]
31. Molecular investigation, using chromosomal microarray and whole exome sequencing, of six patients affected by Williams Beuren syndrome and Autism Spectrum Disorder.
Masson J; Demily C; Chatron N; Labalme A; Rollat-Farnier PA; Schluth-Bolard C; Gilbert-Dussardier B; Giuliano F; Touraine R; Tordjman S; Verloes A; Testa G; Sanlaville D; Edery P; Lesca G; Rossi M
Orphanet J Rare Dis; 2019 May; 14(1):121. PubMed ID: 31151468
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
[TBL] [Abstract][Full Text] [Related]
33. Applying whole exome sequencing in a consanguineous population with autism spectrum disorder.
Al-Mamari W; Idris AB; Al-Thihli K; Abdulrahim R; Jalees S; Al-Jabri M; Gabr A; Al Murshedi F; Al Kindy A; Al-Hadabi I; Bruwer Z; Islam MM; Alsayegh A
Int J Dev Disabil; 2023; 69(2):190-200. PubMed ID: 37025335
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of Diagnostic Exome Sequencing in Patients With Diagnosed or Suspected Autism Spectrum Disorders.
Rossi M; El-Khechen D; Black MH; Farwell Hagman KD; Tang S; Powis Z
Pediatr Neurol; 2017 May; 70():34-43.e2. PubMed ID: 28330790
[TBL] [Abstract][Full Text] [Related]
35. Can clinical characteristics be criteria to perform chromosomal microarray analysis in children and adolescents with autism spectrum disorders?
Sys M; van den Bogaert A; Roosens B; Lampo A; Jansen A; Wouters S; Keymolen K
Minerva Pediatr; 2018 Jun; 70(3):225-232. PubMed ID: 27607483
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive Genetic Analysis of Non-syndromic Autism Spectrum Disorder in Clinical Settings.
Ohashi K; Fukuhara S; Miyachi T; Asai T; Imaeda M; Goto M; Kurokawa Y; Anzai T; Tsurusaki Y; Miyake N; Matsumoto N; Yamagata T; Saitoh S
J Autism Dev Disord; 2021 Dec; 51(12):4655-4662. PubMed ID: 33590427
[TBL] [Abstract][Full Text] [Related]
37. A population-based cost-effectiveness study of early genetic testing in severe epilepsies of infancy.
Howell KB; Eggers S; Dalziel K; Riseley J; Mandelstam S; Myers CT; McMahon JM; Schneider A; Carvill GL; Mefford HC; ; Scheffer IE; Harvey AS
Epilepsia; 2018 Jun; 59(6):1177-1187. PubMed ID: 29750358
[TBL] [Abstract][Full Text] [Related]
38. Systematic evaluation of genome sequencing for the diagnostic assessment of autism spectrum disorder and fetal structural anomalies.
Lowther C; Valkanas E; Giordano JL; Wang HZ; Currall BB; O'Keefe K; Pierce-Hoffman E; Kurtas NE; Whelan CW; Hao SP; Weisburd B; Jalili V; Fu J; Wong I; Collins RL; Zhao X; Austin-Tse CA; Evangelista E; Lemire G; Aggarwal VS; Lucente D; Gauthier LD; Tolonen C; Sahakian N; Stevens C; An JY; Dong S; Norton ME; MacKenzie TC; Devlin B; Gilmore K; Powell BC; Brandt A; Vetrini F; DiVito M; Sanders SJ; MacArthur DG; Hodge JC; O'Donnell-Luria A; Rehm HL; Vora NL; Levy B; Brand H; Wapner RJ; Talkowski ME
Am J Hum Genet; 2023 Sep; 110(9):1454-1469. PubMed ID: 37595579
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive prenatal diagnostics: Exome versus genome sequencing.
Miceikaite I; Fagerberg C; Brasch-Andersen C; Torring PM; Kristiansen BS; Hao Q; Sperling L; Ibsen MH; Löser K; Bendsen EA; Ousager LB; Larsen MJ
Prenat Diagn; 2023 Aug; 43(9):1132-1141. PubMed ID: 37355983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
